Total buying$00 buys
SNGX
SOLIGENIX, INC.
NasdaqHealthcarePHARMACEUTICAL PREPARATIONS
Insider activity for last month from 10/03 to 11/03.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$00 sells
Net open-market+$0Buying minus selling
Active insiders7Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 13, 2026
Open-market transaction mix · 0 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Oct 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
| Nov 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
Distinct insiders active
Reporting-owner CIKs by month · peak Oct 2026 (7)Oct 2026Nov 2026
Largest insider activity
By absolute net disclosed value · current transaction page- ZB+$0
- RJ+$0
- PL+$0
- LG+$0
SNGX transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period38transactionstxns
- D · Issuer dispositions · dominant38 · 100%
Activity by reported role
A joint filing can contribute to multiple rolesDirector24
CSO6
Chief executive officer4
Chief financial officer4
CHAIR4
PRES4
Reported Holdings After
Separated by insider, security, and ownership type
Donini OreolaStock Option (Right to Buy) · Direct
0Oct 12, 2026
Lapointe Anthony GreggStock Option (Right to Buy) · Direct
0Oct 12, 2026
Parks Diane L.Stock Option (Right to Buy) · Direct
0Oct 12, 2026
Rubin Robert J.Stock Option (Right to Buy) · Direct
0Oct 12, 2026
Zeldis Jerome BStock Option (Right to Buy) · Direct
0Oct 12, 2026
Schaber Christopher JStock Option (Right to Buy) · Direct
0Oct 12, 2026
Guarino Jonathan L.Stock Option (Right to Buy) · Direct
0Oct 12, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redOct 03 → Nov 03
LessMore
SOLIGENIX, INC. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at SOLIGENIX, INC.?
ZELDIS JEROME B, RUBIN ROBERT J., Parks Diane L., LAPOINTE ANTHONY GREGG, Donini Oreola, Guarino Jonathan L., SCHABER CHRISTOPHER J.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.